Christopher Boerner - Chief Executive Officer, Director at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Boerner since 12/22/2023

Holdings reported by Christopher Boerner for Bristol Myers Squibb Co

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 103K $5.57M $54.32 Nov 1, 2024 Direct
Common Stock, $0.10 par value 101K $5.44M $53.79 Mar 10, 2024 Direct
Market Share Units 8.89K $471K $52.99 Nov 1, 2024 Direct Common Stock, $0.10 par value
Performance Shares 148K Mar 10, 2024 Direct Common Stock, $0.10 par value
Restricted Stock Units 0 $50.10 Dec 2, 2023 Direct Common Stock, $0.10 par value

Transactions reported by Christopher Boerner for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.